Table 2 Exposure to potential drug–drug interactions stratified with respect to patients’ characteristics
Characteristics | All types of interactions (n = 534) | Only major interactions (n = 225) |
|---|---|---|
n (%a) | n (%a) | |
Gender | ||
Male | 230 (21.1) | 101 (9.3) |
Female | 304 (23.2) | 124 (9.5) |
Age (Years) | ||
≤ 10 | 41 (5.4) | 64 (8.4) |
11–20 | 79 (20.5) | 32 (8.3) |
21–30 | 129 (29.1) | 44 (9.9) |
31–40 | 87 (28.1) | 28 (9) |
41–50 | 100 (34.2) | 37 (12.7) |
51–60 | 59 (42.8) | 12 (8.7) |
> 60 | 39 (60) | 8 (12.3) |
Prescribed medicines | ||
≤ 3 | 141 (14.7) | 95 (9.9) |
4–6 | 315 (25.5) | 115 (9.3) |
> 6 | 78 (38.4) | 15 (7.4) |
Clinical Specialties | ||
Medicine | 221 (32.2) | 58 (8.4) |
Pediatrics | 31 (5.1) | 56 (9.2) |
Dermatology | 15 (6.4) | 19 (8.1) |
Ear Nose and Throat | 36 (18.9) | 17 (8.9) |
Surgical | 31 (23.5) | 12 (9.1) |
Chest | 37 (29.8) | 13 (10.5) |
Psychiatry | 58 (50.9) | 11 (9.6) |
Cardiology | 62 (69.7) | 12 (13.5) |
Gynecology | 19 (24.4) | 13 (16.7) |
Orthopedic | 12 (16.4) | 10 (13.7) |
Dentistry | 4 (10.3) | 3 (7.7) |
Miscellaneous | 8 (27.6) | 1 (3.4) |